Mutual of America Capital Management LLC Has $2 Million Stock Position in Cabot Corporation $CBT

Mutual of America Capital Management LLC lowered its holdings in Cabot Corporation (NYSE:CBT) by 4.3% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 26,718 shares of the specialty chemicals company’s stock after selling 1,189 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Cabot were worth $2,004,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CBT. LSV Asset Management grew its holdings in Cabot by 318.0% in the 1st quarter. LSV Asset Management now owns 571,034 shares of the specialty chemicals company’s stock valued at $47,476,000 after buying an additional 434,434 shares during the last quarter. American Century Companies Inc. grew its holdings in shares of Cabot by 13.2% during the 1st quarter. American Century Companies Inc. now owns 1,498,268 shares of the specialty chemicals company’s stock worth $124,566,000 after purchasing an additional 174,921 shares in the last quarter. AQR Capital Management LLC grew its holdings in shares of Cabot by 79.5% during the 1st quarter. AQR Capital Management LLC now owns 389,244 shares of the specialty chemicals company’s stock worth $31,626,000 after purchasing an additional 172,410 shares in the last quarter. Nuveen LLC acquired a new stake in shares of Cabot during the 1st quarter worth approximately $12,365,000. Finally, Caisse DE Depot ET Placement DU Quebec grew its holdings in shares of Cabot by 279.2% during the 1st quarter. Caisse DE Depot ET Placement DU Quebec now owns 160,628 shares of the specialty chemicals company’s stock worth $13,355,000 after purchasing an additional 118,266 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on CBT. Mizuho decreased their price objective on Cabot from $90.00 to $88.00 and set an “outperform” rating on the stock in a report on Friday, October 3rd. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a report on Friday. Finally, UBS Group set a $82.00 price objective on Cabot and gave the stock a “neutral” rating in a report on Tuesday, August 5th. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Cabot currently has a consensus rating of “Hold” and a consensus price target of $85.00.

Insider Buying and Selling

In other Cabot news, CEO Sean D. Keohane sold 114,436 shares of the business’s stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $79.28, for a total value of $9,072,486.08. Following the transaction, the chief executive officer owned 361,518 shares of the company’s stock, valued at approximately $28,661,147.04. The trade was a 24.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 3.03% of the company’s stock.

Cabot Price Performance

Cabot stock opened at $71.31 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.41 and a current ratio of 2.13. The firm has a market cap of $3.79 billion, a P/E ratio of 9.32 and a beta of 0.88. The business’s fifty day moving average is $76.52 and its two-hundred day moving average is $76.48. Cabot Corporation has a 52 week low of $66.50 and a 52 week high of $117.46.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Monday, August 4th. The specialty chemicals company reported $1.90 EPS for the quarter, topping analysts’ consensus estimates of $1.80 by $0.10. The company had revenue of $923.00 million for the quarter, compared to analyst estimates of $957.29 million. Cabot had a return on equity of 25.68% and a net margin of 11.14%. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. Equities research analysts forecast that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.